OS Therapies OSTX Net proceeds from sale of equity interest
Net proceeds from sale of equity interest at other companies
Other financials
Where this comes from
Reported directly by OS Therapies in its filing.
Tagged under the XBRL concept us-gaap:ProceedsFromOtherEquity.
The official record: OS Therapies’s 10-Q, filed May 18, 2026, on SEC EDGAR. View the filing →
Ask your AI about OS Therapies's net proceeds from sale of equity interest.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is OS Therapies's net proceeds from sale of equity interest?
- OS Therapies (OSTX) reported net proceeds from sale of equity interest of $3.38M in Q1 2026.
- How has OS Therapies's net proceeds from sale of equity interest changed year-over-year?
- OS Therapies's net proceeds from sale of equity interest increased by 2447.3% year-over-year, from $132.54K to $3.38M.
- What does net proceeds from sale of equity interest mean?
- Refers to cash inflows generated from the sale or issuance of equity interests other than standard common or preferred stock offerings. This captures alternative capital-raising activities that impact the company's total equity structure.